Immediate Impact
9 standout
Citing Papers
Advances in targeting histone deacetylase for treatment of solid tumors
2024 Standout
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
Works of Peter Schmid being referenced
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Abstract GS1-11: Sacituzumab Govitecan (SG) vs Treatment of Physician’s Choice (TPC): Efficacy by Trop-2 Expression in the TROPiCS-02 Study of Patients (Pts) With HR+/HER2– Metastatic Breast Cancer (mBC)
2023
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peter Schmid | 191 | 105 | 45 | 58 | 11 | 224 | |
| T. Valdez | 234 | 141 | 61 | 73 | 16 | 275 | |
| Mariela Blum‐Murphy | 133 | 95 | 43 | 41 | 9 | 227 | |
| Daniel Barrios | 207 | 92 | 23 | 84 | 12 | 254 | |
| Q. Hong | 192 | 95 | 26 | 49 | 8 | 233 | |
| Míriam Arumí | 112 | 79 | 47 | 37 | 12 | 169 | |
| Mojca Unk | 132 | 114 | 23 | 65 | 14 | 187 | |
| Eileen Wrabel | 214 | 53 | 71 | 139 | 13 | 267 | |
| Elisa Minenza | 177 | 115 | 31 | 32 | 12 | 240 | |
| Marcelle Goldner Cesca | 216 | 74 | 95 | 87 | 17 | 259 | |
| Larry Schlabach | 181 | 147 | 26 | 27 | 10 | 295 |
All Works
Loading papers...